Improving Flexibility and Quality of Life for Your Patients: A Must? Axel Heidenreich  European Urology Supplements  Volume 8, Issue 12, Pages 857-862 (December 2009) DOI: 10.1016/j.eursup.2009.09.004 Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 1 Rate of incident coronary heart disease, myocardial infarction, and sudden cardiac death in prostate cancer patients receiving androgen-deprivation therapy (ADT) or no treatment [12]. European Urology Supplements 2009 8, 857-862DOI: (10.1016/j.eursup.2009.09.004) Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 2 The median percent decrease from baseline in hot flush frequency and hot flush score after 4 wk of treatment with placebo or gabapentin 300, 600, or 900mg/d [19]. European Urology Supplements 2009 8, 857-862DOI: (10.1016/j.eursup.2009.09.004) Copyright © 2009 European Association of Urology Terms and Conditions